Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Turk Osteoporoz Dergisi is Scopus-indexed (Q4, CiteScore 0.6), WoS ESCI, DOAJ. Published by Galenos Publishing House.
Checked against the index lists dated .
ISSN 2146-3816Verify ISSN ↗2147-2653Verify ISSN ↗
Publisher: Galenos Publishing House
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Endocrinology, Diabetes and Metabolism | 221 / 250 | 11th | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q4, CiteScore 0.6.
Turk Osteoporoz Dergisi is Q4 in Endocrinology, Diabetes and Metabolism (rank 221 of 250), by CiteScore 2025.
Turk Osteoporoz Dergisi is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.6, which places it in quartile Q4 at the 11th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.195, quartile Q4, with an H-index of 7.
Turk Osteoporoz Dergisi is published by Galenos Publishing House. Its print ISSN is 2146-3816 and its online ISSN is 2147-2653.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Turk Osteoporoz Dergisi has an h-index of 14 and a 2-year mean of 1 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #169 of 246 Scopus journals in Endocrinology, Diabetes and Metabolism.
Turk Osteoporoz Dergisi published 51 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 75 research articles (2024–2026), authors are most often from Türkiye (86.7%), India (2.7%) and Iran (1.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.